↓ Skip to main content

Nanoparticles in the clinic

Overview of attention for article published in Bioengineering & Translational Medicine, June 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#4 of 113)
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
2 blogs
twitter
37 tweeters
patent
1 patent
facebook
3 Facebook pages

Citations

dimensions_citation
425 Dimensions

Readers on

mendeley
748 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nanoparticles in the clinic
Published in
Bioengineering & Translational Medicine, June 2016
DOI 10.1002/btm2.10003
Pubmed ID
Authors

Aaron C. Anselmo, Samir Mitragotri

Abstract

Nanoparticle/microparticle-based drug delivery systems for systemic (i.e., intravenous) applications have significant advantages over their nonformulated and free drug counterparts. For example, nanoparticle systems are capable of delivering therapeutics and treating areas of the body that other delivery systems cannot reach. As such, nanoparticle drug delivery and imaging systems are one of the most investigated systems in preclinical and clinical settings. Here, we will highlight the diversity of nanoparticle types, the key advantages these systems have over their free drug counterparts, and discuss their overall potential in influencing clinical care. In particular, we will focus on current clinical trials for nanoparticle formulations that have yet to be clinically approved. Additional emphasis will be on clinically approved nanoparticle systems, both for their currently approved indications and their use in active clinical trials. Finally, we will discuss many of the often overlooked biological, technological, and study design challenges that impact the clinical success of nanoparticle delivery systems.

Twitter Demographics

The data shown below were collected from the profiles of 37 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 748 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Chile 1 <1%
Mexico 1 <1%
Estonia 1 <1%
Unknown 743 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 240 32%
Student > Master 115 15%
Researcher 92 12%
Student > Bachelor 70 9%
Student > Doctoral Student 36 5%
Other 89 12%
Unknown 106 14%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 114 15%
Chemistry 107 14%
Biochemistry, Genetics and Molecular Biology 95 13%
Agricultural and Biological Sciences 76 10%
Engineering 54 7%
Other 168 22%
Unknown 134 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2019.
All research outputs
#533,562
of 15,010,975 outputs
Outputs from Bioengineering & Translational Medicine
#4
of 113 outputs
Outputs of similar age
#15,051
of 264,457 outputs
Outputs of similar age from Bioengineering & Translational Medicine
#1
of 11 outputs
Altmetric has tracked 15,010,975 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 113 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,457 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.